(Q87327728)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Ezetimibe in the balance: can cholesterol-lowering drugs alone be an effective therapy for NAFLD? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Giovanni Musso

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

20 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

850-855

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis

8 March 2020

cites work

1 reference

12 December 2020

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

1 reference

12 December 2020

Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease

1 reference

12 December 2020

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation

1 reference

12 December 2020

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

12 December 2020

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

1 reference

12 December 2020

Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.

1 reference

12 December 2020

Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance?

1 reference

12 December 2020

Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.

1 reference

12 December 2020

Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field

1 reference

12 December 2020

Hepatic adverse effects of fructose consumption independent of overweight/obesity.

1 reference

12 December 2020

Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1.

1 reference

12 December 2020

Effects of simvastatin, atorvastatin, ezetimibe, and ezetimibe + simvastatin combination on the inflammatory process and on the liver metabolic changes of arthritic rats

1 reference

12 December 2020

Inhibition of intestinal cholesterol absorption decreases atherosclerosis but not adipose tissue inflammation

1 reference

12 December 2020

Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet

1 reference

12 December 2020

The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial

1 reference

12 December 2020

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

1 reference

12 December 2020

Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation

1 reference

12 December 2020

Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice

1 reference

12 December 2020

[Simvastatin inhibits activation of hepatic stellate cells and promotes activation of adenosine monophosphate-activated protein kinase].

1 reference

12 December 2020

Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes

1 reference

12 December 2020

Liver transplantation for nonalcoholic steatohepatitis: the new epidemic

1 reference

12 December 2020

Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism

1 reference

12 December 2020

Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia.

1 reference

12 December 2020

Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease

1 reference

12 December 2020

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol

1 reference

12 December 2020

Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs

1 reference

12 December 2020

Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.

1 reference

12 December 2020

SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice

1 reference

12 December 2020

Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein

1 reference

12 December 2020

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

12 December 2020

10.1007/S00125-014-3192-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24554006%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference